Table IV.
Study | Prevalence of AGA in patients with severe COVID-19 |
---|---|
Men | |
Goren et al,14 2020 | 70.7% (29/41) |
Lee et al,16 2020 | 73.5% (247/336) |
Salazar et al,33 2021 | 91.4% (32/35) |
Torabi et al,42 2021 | 73.8% (45/61) |
Wambier et al,45 2020 | 78.7% (96/122) |
Total | 75.5% (449/595) |
Women | |
Torabi et al,42 2021 | 56.1% (32/57) |
Wambier et al,45 2020 | 41.5% (22/53) |
Total | 49.1% (54/110) |
AGA, Androgenic alopecia.